Author:
Hanke Nina,Teifel Michael,Moj Daniel,Wojtyniak Jan-Georg,Britz Hannah,Aicher Babette,Sindermann Herbert,Ammer Nicola,Lehr Thorsten
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference39 articles.
1. Nagy A, Schally A, Armatis P, Szepeshazi K, Halmos G, Kovacs M, Zarandi M, Groot K, Miyazaki M, Jungwirth A, Horvath J (1996) Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500–1000 times more potent. Proc Natl Acad Sci USA 93:7269–7273
2. Westphalen S, Kotulla G, Kaiser F, Krauss W, Werning G, Elsasser HP, Nagy A, Schulz KD, Gründker C, Schally A, Emons G (2000) Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines. Int J Oncol 17:1063–1069
3. Krebs LJ, Wang X, Nagy A, Schally A, Rasad PN, Liebowa C (2002) A conjugate of doxorubicin and an analog of Luteinizing hormone-releasing hormone shows increased efficacy against oral and laryngeal cancers. Oral Oncol 38:657–663
4. Gründker C, Völker P, Griesinger F, Ramaswamy A, Nagy A, Schally A, Emons G (2002) Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice. Am J Obstet Gynecol 187:528–537
5. Szepeshazi K, Schally A, Keller G, Block NL, Benten D, Halmos G, Szalontay L, Vidaurre I, Rick FG (2012) Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108). Oncotarget 3:686–699
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献